Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

16.98
+0.45002.72%
Pre-market: 16.990.0100+0.06%07:11 EDT
Volume:1.14M
Turnover:19.23M
Market Cap:2.17B
PE:-42.21
High:17.08
Open:16.60
Low:16.21
Close:16.53
52wk High:17.08
52wk Low:6.38
Shares:128.00M
Float Shares:117.00M
Volume Ratio:0.78
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.77
PE(LYR):-20.14

Loading ...

Neogenomics Shares Rise 6.5% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 29

NeoGenomics Q2 FY26 Adjusted Ebitda Climbs 36% to $14 Million; Revenue Rises 11% to $202 Million

Reuters
·
Jul 29

NeoGenomics Q2 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $202.000M Beat $196.997M Estimate

Benzinga Earnings
·
Jul 29

NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 Million

Reuters
·
Jul 29

Neogenomics Inc: Decrease in Operating Expenses for Q2 2026 was Primarily Due to $20 Mln of Impairment Charges Taken in Q2 2025

THOMSON REUTERS
·
Jul 29

Neogenomics Q2 Operating Expenses USD 102 Million

THOMSON REUTERS
·
Jul 29

Neogenomics: Sees Fy2026 Adj Ebitda $56 Mln to $58 MLN\n

THOMSON REUTERS
·
Jul 29

Neogenomics: Expects Fy2026 Net Loss of $42 Mln to $34 MLN\n

THOMSON REUTERS
·
Jul 29

Neogenomics Q2 Adjusted Ebitda USD 14 Million

THOMSON REUTERS
·
Jul 29

Neogenomics Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Jul 29

Press Release: NEO Battery Reports Fiscal Year 2027 First Quarter Results

Dow Jones
·
Jul 28

Neogenomics is Maintained at Buy by Benchmark

Dow Jones
·
Jul 24

NeoGenomics price target raised to $16 from $11 at Benchmark

TIPRANKS
·
Jul 24

Earning Preview: NeoGenomics Q2 revenue is expected to increase by 7.83%, and institutional views are bullish

Earnings Agent
·
Jul 22

How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors

Simply Wall St.
·
Jul 21

Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation

Dow Jones
·
Jul 21

NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care

TIPRANKS
·
Jul 21

Neogenomics Settlement Comes in Under Accrued Reserves

Dow Jones
·
Jul 21

Neogenomics Resolves DOJ Investigation

Dow Jones
·
Jul 21

NeoGenomics announces settlement of voluntary disclosure to OIG-HHS

TIPRANKS
·
Jul 21